Integrated Wealth Management (Palm Desert)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-602	Closed	-$56K	–	319
2016 Q3	$56K	Hold	602	–	–	0.02%	392
2016 Q2	$47K	Hold	602	–	–	0.02%	417
2016 Q1	$50K	Hold	602	–	–	0.02%	379
2015 Q4	$63K	Hold	602	–	–	0.03%	349
2015 Q3	$63K	Hold	602	–	–	0.03%	336
2015 Q2	$82K	Sell	602 -14	-2%	-$1.74K	0.03%	303
2015 Q1	$76K	Buy	+616	New	+$65.3K	0.03%	309

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s BMRN Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2016, closing a stake of 602 shares — an estimated $56K sold.

Integrated Wealth Management (Palm Desert) first reported a position in BMRN in Q1 2015 and held it in 7 quarters. The position peaked at $82K in Q2 2015. 415 funds tracked by Wall St. Rank hold BMRN as of Q4 2016.

Integrated Wealth Management (Palm Desert) reported no remaining BioMarin Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Integrated Wealth Management (Palm Desert) sold 602 BioMarin Pharmaceuticals shares in Q4 2016, an estimated $56K.
Integrated Wealth Management (Palm Desert) first reported a position in BioMarin Pharmaceuticals in Q1 2015 and held it in 7 quarters.
Integrated Wealth Management (Palm Desert)'s BioMarin Pharmaceuticals position peaked at $82K in Q2 2015.
415 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.